EBITDA for West Pharmaceutical Services (WST)
According to West Pharmaceutical Services's latest reported financial statements, the company's current EBITDA (TTM) is $799.00M USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$799.00M
YoY change
-2.7%
5Y CAGR
+6.9%
Peak year (2021)
$879.70M
Cumulative EBITDA
$9.33B
EBITDA history chart for West Pharmaceutical Services (WST) from 1985 to 2025
EBITDA history table for West Pharmaceutical Services (WST) from 1985 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $723.60M | -2.7% | ||
| 2024 | $743.80M | -11.9% | ||
| 2023 | $844.10M | +4.5% | ||
| 2022 | $808.10M | -8.1% | ||
| 2021 | $879.70M | +69.5% | ||
| 2020 | $518.90M | +28.7% | ||
| 2019 | $403.20M | +14.2% | ||
| 2018 | $353.20M | +8.3% | ||
| 2017 | $326.20M | +13.7% | ||
| 2016 | $286.90M | +31.8% | ||
| 2015 | $217.70M | -21.8% | ||
| 2014 | $278.50M | +10.4% | ||
| 2013 | $252.20M | +26.1% | ||
| 2012 | $200.00M | +9.1% | ||
| 2011 | $183.40M | +13.7% | ||
| 2010 | $161.30M | -3.1% | ||
| 2009 | $166.40M | -10.6% | ||
| 2008 | $186.10M | +18.2% | ||
| 2007 | $157.50M | +5.1% | ||
| 2006 | $149.90M | +22.0% | ||
| 2005 | $122.90M | +30.1% | ||
| 2004 | $94.50M | +11.4% | ||
| 2003 | $84.80M | +2.4% | ||
| 2002 | $82.80M | +10.8% | ||
| 2001 | $74.70M | -1.6% | ||
| 2000 | $75.90M | -25.7% | ||
| 1999 | $102.10M | +5.3% | ||
| 1998 | $97.00M | +3.4% | ||
| 1997 | $93.80M | +11.7% | ||
| 1996 | $84.00M | +7.8% | ||
| 1995 | $77.90M | +11.0% | ||
| 1994 | $70.20M | +11.3% | ||
| 1993 | $63.10M | -0.3% | ||
| 1992 | $63.30M | +172.8% | ||
| 1991 | $23.20M | -47.2% | ||
| 1990 | $43.90M | -22.2% | ||
| 1989 | $56.40M | +14.4% | ||
| 1988 | $49.30M | +5.6% | ||
| 1987 | $46.70M | +2.6% | ||
| 1986 | $45.50M | +28.2% | ||
| 1985 | $35.50M | — |
EBITDA values are taken from West Pharmaceutical Services's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, West Pharmaceutical Services (WST) EBITDA totalled $723.60M – edged down 2.7% year-over-year.
West Pharmaceutical Services EBITDA has recorded the values shown across consecutive periods, with a +6.9% compound annual growth rate over 2020–2025 (5 years).
West Pharmaceutical Services EBITDA peaked at $879.70M in 2021; the latest annual figure is $723.60M in 2025 (17.7% below peak).
2021 marks the peak EBITDA at $879.70M, with the historical low of $23.20M recorded in 1991.
Among 8 Healthcare peers, West Pharmaceutical Services (WST) ranks 9th; the peer median for EBITDA is $24.21B.
West Pharmaceutical Services EBITDA by Year
West Pharmaceutical Services EBITDA 2025: $723.60M
West Pharmaceutical Services EBITDA in 2025 was $723.60M, edged down 2.7% below 2024.
West Pharmaceutical Services EBITDA 2024: $743.80M
West Pharmaceutical Services EBITDA in 2024 was $743.80M, declined 11.9% below 2023.
West Pharmaceutical Services EBITDA 2023: $844.10M
West Pharmaceutical Services EBITDA in 2023 was $844.10M, edged up 4.5% from 2022.
West Pharmaceutical Services EBITDA 2022: $808.10M
West Pharmaceutical Services EBITDA in 2022 was $808.10M, declined 8.1% below 2021.
West Pharmaceutical Services EBITDA 2021: $879.70M
West Pharmaceutical Services EBITDA in 2021 was $879.70M.
See more financial history for West Pharmaceutical Services (WST).
Sector peers — EBITDA
Companies in the same sector as West Pharmaceutical Services, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is West Pharmaceutical Services's EBITDA?
- Latest reported EBITDA for West Pharmaceutical Services (WST) is $799.00M (period ending March 31, 2026).
How has West Pharmaceutical Services EBITDA changed year-over-year?
- West Pharmaceutical Services (WST) EBITDA changed -2.7% year-over-year on the latest annual filing.
What is the long-term growth rate of West Pharmaceutical Services EBITDA?
- West Pharmaceutical Services (WST) EBITDA compound annual growth rate is +6.9% over the most recent 5 years available.
When did West Pharmaceutical Services EBITDA hit its highest annual value?
- West Pharmaceutical Services EBITDA reached its highest annual value of $879.70M in 2021.
What was West Pharmaceutical Services EBITDA in 2024?
- West Pharmaceutical Services (WST) EBITDA in 2024 was $743.80M.
What was West Pharmaceutical Services EBITDA in 2025?
- West Pharmaceutical Services (WST) EBITDA in 2025 was $723.60M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
WST Overview
Company profile, financial tools, and key metrics
WST Revenue Counter
Earns $102.12 every second. See per minute, hour, and day.
WST Earnings Counter
Earns $17.21 per second net profit. See per minute, hour, and day.
WST Economic Scale
Exceeds Belize's GDP. Compare with world economies.
WST What If Invested
What if you had invested $1,000? See historical returns from any date.
WST How It Makes Money
Discover visual breakdown of $3.22B in revenue — where it comes from and where it goes.
WST Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
WST Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
WST Daily Price Character
Steady · 44.8% historical win rate (green days). Streaks & record days.
WST Buybacks
1.65% TTM buyback yield. Shareholder yield & SBC comparison.
WST Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
WST Dividend Profile
Yield: 0.29%. Safety: 6/8. See full history.
WST Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
WST Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.